Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T van Gelder

Showing results (11-20 of 169) with videos related to

Pageof 17
Sort By:
The New England Journal of Medicine|June 22, 1995
Epstein-Barr virus in smooth-muscle tumorsT van Gelder, V D Vuzevski, W Weimar
Nederlands Tijdschrift Voor Geneeskunde|July 2, 2020
[Pharmacogenetics in daily practice]T van Gelder, R H N van Schaik
Nederlands Tijdschrift Voor Geneeskunde|August 10, 1991
[Horner's syndrome: can we turn a blind eye?]T van Gelder, H M van Gemert, A Staal
Therapeutic Drug Monitoring|October 18, 2000
Drug interaction between mycophenolate mofetil and tacrolimus detectable within therapeutic mycophenolic acid monitoring in renal transplant patientsT van Gelder, P J Smak Gregoor, W Weimar
The European Respiratory Journal|June 1, 1994
Prognostic factors and survival in malignant pleural mesotheliomaT Van Gelder, R A Damhuis, H C Hoogsteden
The Netherlands Journal of Medicine|December 2, 2000
Mycophenolate mofetil, Cellcept, a new immunosuppressive drug with great potential in internal medicineP J Smak Gregoor, T van Gelder, W Weimar
Clinical Pharmacology and Therapeutics|August 23, 2012
Individualization of tamoxifen treatment for breast carcinomaL Binkhorst, T van Gelder, R H J Mathijssen
Clinical Pharmacology and Therapeutics|September 3, 2013
Practicability of pharmacogenetics in transplantation medicineT van Gelder, R H van Schaik, D A Hesselink
Toxicology Reports|October 23, 2023
Treatment of a life-threatening dapsone intoxicationM H Veerman, T van Gelder, R Sneijder, et al.
Clinical Neurology and Neurosurgery|January 1, 1991
A patient with megaloblastic anaemia and idiopathic intracranial hypertension. Case historyT van Gelder, H M van Gemert, H L Tjiong
Pageof 17

Showing results (11-20 of 169) with videos related to

Sort By:
Pageof 17
The New England Journal of Medicine|June 22, 1995
Epstein-Barr virus in smooth-muscle tumorsT van Gelder, V D Vuzevski, W Weimar
Nederlands Tijdschrift Voor Geneeskunde|July 2, 2020
[Pharmacogenetics in daily practice]T van Gelder, R H N van Schaik
Nederlands Tijdschrift Voor Geneeskunde|August 10, 1991
[Horner's syndrome: can we turn a blind eye?]T van Gelder, H M van Gemert, A Staal
Therapeutic Drug Monitoring|October 18, 2000
Drug interaction between mycophenolate mofetil and tacrolimus detectable within therapeutic mycophenolic acid monitoring in renal transplant patientsT van Gelder, P J Smak Gregoor, W Weimar
The European Respiratory Journal|June 1, 1994
Prognostic factors and survival in malignant pleural mesotheliomaT Van Gelder, R A Damhuis, H C Hoogsteden
The Netherlands Journal of Medicine|December 2, 2000
Mycophenolate mofetil, Cellcept, a new immunosuppressive drug with great potential in internal medicineP J Smak Gregoor, T van Gelder, W Weimar
Clinical Pharmacology and Therapeutics|August 23, 2012
Individualization of tamoxifen treatment for breast carcinomaL Binkhorst, T van Gelder, R H J Mathijssen
Clinical Pharmacology and Therapeutics|September 3, 2013
Practicability of pharmacogenetics in transplantation medicineT van Gelder, R H van Schaik, D A Hesselink
Toxicology Reports|October 23, 2023
Treatment of a life-threatening dapsone intoxicationM H Veerman, T van Gelder, R Sneijder, et al.
Clinical Neurology and Neurosurgery|January 1, 1991
A patient with megaloblastic anaemia and idiopathic intracranial hypertension. Case historyT van Gelder, H M van Gemert, H L Tjiong
Pageof 17